Search results for " industry 4.0" in Articles / App Notes
Article
Webinar: Establishing a CHO-K1 cell line and cell line development process for biotherapeutics markets
Establishing a robust cell line is a critical step in the development of a biotherapeutic. But how can you meet rapid timelines when the cell line development workflow is challenged by doc…
Article
What’s in your media? How costly is variability of cell culture media to your manufacturing process?
Manufacturing
In this video, Christopher Woolstenhulme, Lead Analytical Scientist of Manufacturing Sciences at Cytiva, is interviewed by BioPharm International and provides insight into t…
Article
Upstream Processing: Biochemicals and Raw Materials
Experts reveal how to identify the “right” biochemical, the process of sourcing biochemicals, sourcing challenges, and what industry professionals should know about the space.
…
Article
Join the Plasma Product Biotechnology Meeting
We are pleased to announce the 12th International Plasma Product Biotechnology Meeting to be held in Limassol, Cyprus, 31 October - 3 November, 2022.
The Plasma Product Biotechnology Con…
Article
Take part of the Southeast Asia BioChallenge
Looking to create the next breakthrough innovation? Cytiva is here to support you to bring your molecule to market in the shortest possible time. By applying to our BioChallenge, you stand …
Article
Tools and methodologies for smarter downstream process development
Scibetta
Smart process development is a collection of approaches to improve process outcomes and speed up process development.
In this video, John Scibetta, Advanced Chromatogra…
Article
Advanced therapeutics process development using mechanistic modeling
Guterstam
Watch the interview of Peter Guterstam and Nick Whitelock (Cytiva), and learn about
the biological background of advanced therapeutics
what mechanistic modelling …
Article
Get to know: mAb variants - eLearning
The diversity of antibody variants in the biotherapeutics pipeline are increasing with a growing interest for molecules like antibody fragments and bispecific antibodies (bsAbs). Cytiva has pu…
Article
Q&A: Oligonucleotide synthesis in process development and scale-up
Farlow
In this video, Greg Farlow, RNA/DNA synthesis product specialist at Cytiva, talks about the typical challenges with oligonucleotide synthesis in process development and key cons…
Article
Late stage failures of monoclonal antibodies
Despite the significant developments that have happened in clinical trial design and the considerable experience that the biopharma industry has gained in the past three decades, therapeutic…